Novel therapeutic strategy based on genetic and epigenetic abnormalities for myeloid neoplasms Takahiro Yamauchi Introduction to Invited Review Articles 18 May 2019 Pages: 883 - 884
Genetic abnormalities and pathophysiology of MDS Naoko Hosono Invited Review Article 15 May 2019 Pages: 885 - 892
Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01 Kenichi MiyamotoYosuke Minami Invited Review Article Open access 20 May 2019 Pages: 893 - 898
Stereotactic body radiotherapy in patients with chronic obstructive pulmonary disease and interstitial pneumonia: a review Hiroshi DoiKiyoshi NakamatsuYasumasa Nishimura Review Article 01 April 2019 Pages: 899 - 909
Immune check-point in endometrial cancer Francesca De FeliceClaudia MarchettiP. Benedetti Panici Review Article 02 May 2019 Pages: 910 - 916
Real-world treatment of over 1600 Japanese patients with EGFR mutation-positive non-small cell lung cancer with daily afatinib Kazuo TamuraToshihiro NukiwaYoichi Nakanishi Original Article Open access 05 April 2019 Pages: 917 - 926
FDG-PET might not contribute to improving survival in patients with locally advanced inoperable esophageal cancer Keiichi JinguRei UmezawaHaruo Matsushita Original Article 12 March 2019 Pages: 927 - 933
Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study Jin-Li WeiYi-Zhou JiangZhi-Min Shao Original Article 19 March 2019 Pages: 934 - 940
Removal of the entire internal iliac vessel system is a feasible surgical procedure for locally advanced ovarian carcinoma adhered firmly to the pelvic sidewall Kyoko NishikimiShinichi TateMakio Shozu Original Article 20 March 2019 Pages: 941 - 949
Comparison of long-term oncologic outcomes between metastatic ovarian carcinoma originating from gastrointestinal organs and advanced mucinous ovarian carcinoma Hiroaki KajiyamaShiro SuzukiFumitaka Kikkawa Original Article 02 April 2019 Pages: 950 - 956
Impact of prostate cancer radiotherapy on the biological behavior and specific mortality of subsequent bladder cancer Xiaoxiao GuoMin LiuJianye Wang Original Article 22 March 2019 Pages: 957 - 965
Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12) Kazutaka SunamiMorio MatsumotoKoichi Akashi Original Article 01 April 2019 Pages: 966 - 975
A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma Congwei HuangQinjue WangChengzhe Jin Original Article 20 May 2019 Pages: 976 - 982
Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study Yuji OkuraTsugumi TakayamaTohru Minamino Original Article Open access 22 March 2019 Pages: 983 - 994
Correction to: Future projection of cancer patients with cardiovascular disease in Japan by the year 2039: a pilot study Yuji OkuraTsugumi TakayamaTohru Minamino Correction 22 April 2019 Pages: 995 - 995